1-3 of 3
Charles Lopez, MD PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Oncogenic Splicing of the Apoptosis-Stimulating Protein of p53-2 ( ASPP2 ) Is an Initiating Step in Leukemogenesis Facilitating Acquisition of Structural Genomic Mutations

Kerstin Maria Kampa-Schittenhelm, MD, Ulrike Mau-Holzmann, Charles Lopez, MD PhD, Marcus M. Schittenhelm
Journal: Blood
Blood (2016) 128 (22): 1555.
https://doi.org/10.1182/blood.V128.22.1555.1555
Published: 2016
Journal Articles

Attenuation of Apoptosis-Stimulating Protein of p53-2 (ASPP2) Promotes IL-3-Independent Growth and Enhances Cytogenetic Abnormalities after Gamma-Irradiation in Mouse Hematopoietic Cells - Mimicking Early Leukemogenesis of Therapy-Associated Human AML

Kerstin Maria Kampa-Schittenhelm, MD, Ulrike Mau-Holzmann, Lothar Kanz, Prof. Dr. MD, Charles Lopez, MD PhD, Marcus M Schittenhelm, MD
Journal: Blood
Blood (2015) 126 (23): 2460.
https://doi.org/10.1182/blood.V126.23.2460.2460
Published: 2015
Journal Articles

Apoptosis Stimulating Protein of p53 (ASPP2) Heterozygous Mice Are Lymphoma-Prone and Display Attenuated Apoptosis and Cell Cycle Checkpoints

Kerstin Maria Kampa, MD, Jared Acoba, MD, Dexi Chen, MD, PhD, Hun-Joo Lee, Kelly Beemer, Joel Gay, Zhyi Zhu, Emerson Padiernos, Marcus M Schittenhelm, MD, Lothar Kanz, MD, Christopher Corless, MD, PhD, Charles Lopez, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 2844.
https://doi.org/10.1182/blood.V112.11.2844.2844
Published: 2008